Skip to main content
. 2021 Dec 16;8(1):e650. doi: 10.1212/NXG.0000000000000650

Figure 4. Clinically Actionable Genetic Findings, Overall and Among Individuals With Pharmacoresistant Seizures.

Figure 4

(A) All definitive molecular diagnoses and (B) definitive molecular diagnoses with pharmacoresistant seizures were categorized according to whether the diagnostic finding was in a gene with a published clinical action and if so, the type (ASM indications, ASM contraindications, metabolic treatments, possible surgical indications, or surgical contraindications). Individuals with clinically actionable findings in more than 1 category were counted more than once. A full list of clinically actionable genetic findings can be found in eTable 3 (links.lww.com/NXG/A505). ASM = antiseizure medication.